Clinical Trial: Patent Foramen Ovale in Cryptogenic Stroke Study
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Patent Foramen Ovale in Cryptogenic Stroke Study
Brief Summary: The study sought to assess the rate of recurrent stroke and death in stroke patients with a patent foramen ovale randomized to treatment with warfarin or aspirin. This was a multicenter study conducted at 48 U.S. Institutions.
Detailed Summary:
Sponsor: Columbia University
Current Primary Outcome: Recurrent ischemic stroke and death [ Time Frame: 2 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Columbia University
Dates:
Date Received: June 11, 2008
Date Started: June 1993
Date Completion:
Last Updated: September 14, 2011
Last Verified: September 2011